Impact of AI-Based Diagnostics on Patient* Acceptance: An Investigation in the Context of Breast Cancer Screening

Impact of AI-Based Diagnostics on Patient* Acceptance: An Investigation in the Context of Breast Cancer Screening - AI Second Opinion

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

DRKS

Registry ID

DRKS00035010

Enrollment

350

Registered

2024-09-04

Start date

2024-09-04

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

C50

Interventions

Group 1: First opinion: Physican Second opinion: AI Diagnoses are consistent Group 2: First opinion: Physican Second opinion: AI Diagnoses are not consistent Group 3: First opinion: AI Second opinio

Eligibility

Sex/Gender

Female

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: German native language, residing in Germany

Exclusion criteria

Exclusion criteria: Age below minimum age

Design outcomes

Primary

Measure	Time frame
Acceptance of the diagnosis (behavioral decision to schedule an appointment)	—

Secondary

Measure	Time frame
Trust in the diagnosis	—

Countries

Germany

Contacts

Public ContactNiklas von Kalckreuth

Technische Universität Berlin

niklas.vkalckreuth@tu-berlin.de+49 30 314 70747

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026